Stockreport

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

BiomX Inc. COmmon Stock  (PHGE) 
PDF Recent acquisition of Adaptive Phage Therapeutics creates leader in phage therapy with advanced, clinical-stage pipeline     Closed concurrent $50 million financing to [Read more]